HOYA may make comments and disclose information which include forward-looking statements with respect to HOYA's plans and future performance. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements and are based on management´s assumptions and beliefs in light of the information available when such statements were prepared, including exchange and interest rates, international situations, market trends and economic conditions, competition, production capacity, estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory, clinical or research and development capabilities, results or practices, customer patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems such as COVID-19, and other such estimates and results. HOYA does not guarantee the accuracy or completeness of such information and HOYA does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.
Record quarterly sales and pretax profit amid a challenging global external environment
Life Care business maintained momentum: all major products achieved sales growth
In the Information Technology business, although the shrinkage of HDD substrates increased and imaging sales also declined, robust sales of the semiconductor blanks and the FX contributed to overall growth
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Hoya Corporation published this content on 27 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 October 2022 04:43:07 UTC.
Hoya Corporation specialises in the manufacture and commercialisation of optical products. Net sales break down by business segment as follows:
- health (66%): manufacturing of health care products (75.4% of sales; eyeglass lenses and contact lenses) and medical products (24.6%; endoscopes, medical accessories, intraocular lenses, artificial bones and metal implants for orthopedics);
- information technology (33.1%): manufacturing of electronic products (78.2% of sales; photomasks for semiconductors, masks and devices for LCD screens and hard disks) and imaging products (21.8%; optical lenses, optical glasses and laser equipment);
- other (0.9%).
Net sales are distributed geographically as follows: Japan (28.9%), China (8.2%), Asia (24.7%), Europe (19.3%), the United States (15.1%), the Americas (2.4%) and others (1.4%).
HOYA CORPORATION 
